Type 2 Diabetes Therapies
Diabetes Management
Phase 2/3Active
Key Facts
About Pfizer
Founded in 1849, Pfizer has evolved into a global biopharmaceutical leader with a comprehensive portfolio spanning vaccines, oncology treatments, and medicines for chronic diseases. The company operates extensive R&D programs across four key therapeutic areas and maintains a robust clinical pipeline with programs in all phases of development. Led by CEO Albert Bourla, Pfizer continues to drive innovation through strategic partnerships and significant investments in breakthrough science.
View full company profileTherapeutic Areas
Other Diabetes Management Drugs
| Drug | Company | Phase |
|---|---|---|
| Diabetology Portfolio | Torrent Pharmaceuticals | Commercial |
| Blood Glucose Monitoring (Glutest) | Nipro Corporation | Commercial |
| Metabolic Disorder Treatments | RPG Life Sciences | Commercial |
| ALRT Diabetes Solution | ALR Technologies | Approved/Commercial |